Excessive intake of sucrose is a major driver of obesity and other diseases, such as non-alcoholic fatty liver diseases (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH). In addition, a ...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD patients are at higher risk of developing Non-alcoholic steatohepatitis (NASH), which ...
Apart from lifestyle interventions, there are currently no approved treatments for NASH. A liver transplant is sometimes the only remedy. While risk factors for NASH (obesity, type-2 diabetes and gene ...
This condition happens when too much fat builds up in the liver. Over time, this can lead to long-term inflammation, scarring ...
The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most widespread disorders worldwide, is expected to rise by more than 50% by 2030. Non-alcoholic fatty liver (NAFL), the initial ...
As the ketogenic diet becomes more popular, new studies warn of potential long-term risks-from liver dysfunction and ...
Bepirovirsen, an investigational antisense oligonucleotide, led to sustained virologic response and a sustained decrease in hepatitis B virus (HBV) DNA, without the need for rescue medication, in ...
Fatty liver disease has become a widespread health issue, which affects people across the world. The rising number of people affected by this condition leads to multiple false beliefs about it which ...